|
|
News Breaks
|
November 9, 2009
|
| 15:37 EDT |  | HSP |
| theflyonthewall.com: | FDA notifies Hospira of Propofol and Lipsoyn recalls | | Hospira and FDA notified healthcare professionals of the recall of 85 lots of Liposyn II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20%, and Liposyn III 30%, and 73 lots of Propofol Injectable Emulsion 1% products that begin with the lot numbers 79 and 80 because some of the containers may contain particulate matter. Reference Link :theflyonthewall.com |
|
|
News For HSP From The Last 14 Days Check below for free stories on HSP the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
January 30, 2012
|
| 16:06 EDT |  | HSP |
| theflyonthewall.com: | Hospira names Richard Davies Chief Commercial Officer | | Hospira announced that Richard Davies has been named senior vice president and chief commercial officer. In this role, he will be responsible for developing and executing Hospira's global commercial strategies and delivering profitable revenue growth across the company's product portfolio. Mr. Davies will join Hospira Feb. 2 and serve as a member of Hospira's senior leadership team, reporting to F. Michael Ball, CEO. :theflyonthewall.com |
|
|
|
|
|